{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:13:35Z","timestamp":1762283615191,"version":"build-2065373602"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000139","name":"U.S. Environmental Protection Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017091","name":"Sumitomo Chemical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.yrtph.2025.105834","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T02:45:52Z","timestamp":1745981152000},"page":"105834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Mode of action analysis for rat thyroid gland follicular cell tumor formation by MGK-264 and human relevance"],"prefix":"10.1016","volume":"160","author":[{"given":"Junji","family":"Yano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukako","family":"Shimotsuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoki","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas G.","family":"Osimitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian G.","family":"Lake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2025.105834_bib1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.yrtph.2018.07.025","article-title":"Human relevance of follicular thyroid tumors in rodents caused by non-genotoxic substances","volume":"98","author":"Bartsch","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105834_bib2","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00228-005-0056-0","article-title":"Alteration of thyroid hormone homeostasis by antiepileptic drugs in humans: involvement of glucuronosyltransferase induction","volume":"61","author":"Benedetti","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"year":"1989","series-title":"13 Week Dietary Range-Finding Toxicity Study in Rats with MGK-264 (Study No. 551-028)","author":"Blair","key":"10.1016\/j.yrtph.2025.105834_bib3"},{"year":"1991","series-title":"Eighteen Month Dietary Oncogenicity Study in Mice with MGK-264 Insecticide Synergist (Study No. 551-011)","author":"Blair","key":"10.1016\/j.yrtph.2025.105834_bib4"},{"year":"1991","series-title":"One Year Dietary Toxicity Study in Dogs with MGK-264 (Study No. 551-031)","author":"Blair","key":"10.1016\/j.yrtph.2025.105834_bib5"},{"key":"10.1016\/j.yrtph.2025.105834_bib6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bcp.2010.04.034","article-title":"Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels","volume":"80","author":"Bock","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105834_bib7","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/10408440600977677","article-title":"IPCS framework for analyzing the relevance of a cancer mode of action for humans","volume":"36","author":"Boobis","year":"2006","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105834_bib8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.yrtph.2025.105834_bib9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1124\/dmd.108.024190","volume":"37","author":"Buckley","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.yrtph.2025.105834_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/019262339702500109","article-title":"Mechanistic data and risk assessment of selected toxic end points of the thyroid gland","volume":"25","author":"Capen","year":"1997","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2025.105834_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/toxsci\/kfh073","article-title":"Evaluating the human relevance of chemically induced animal tumors","volume":"78","author":"Cohen","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105834_bib12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/713608371","article-title":"The human relevance of information on carcinogenic modes of action: overview","volume":"33","author":"Cohen","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105834_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/edrv-12-2-135","article-title":"The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland","volume":"12","author":"Curran","year":"1991","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.yrtph.2025.105834_bib14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/10408440600975242","article-title":"Thiazopyr and thyroid disruption: case study within the context of the 2006 IPCS Human Relevance Framework for analysis of a cancer mode of action","volume":"36","author":"Dellarco","year":"2006","journal-title":"Crit. Rev. Toxicol."},{"year":"2024","series-title":"Guidance on the Application of the CLP Criteria (Ver 6.0). Guidance to Regulation (EC) No 1272\/2008 on Classification, Labelling and Packaging (CLP) of Substances and Mixtures","key":"10.1016\/j.yrtph.2025.105834_bib15"},{"key":"10.1016\/j.yrtph.2025.105834_bib16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.taap.2006.01.009","article-title":"A mode of action for induction of thyroid gland tumors by Pyrethrins in the rat","volume":"214","author":"Finch","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105834_bib17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00204-020-02961-6","article-title":"A review of species differences in the control of, and response to, chemical-induced thyroid hormone perturbations leading to thyroid cancer","volume":"95","author":"Foster","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105834_bib18","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/ijc.24545","article-title":"Epidemiologic evaluation of pharmaceuticals with limited evidence of carcinogenicity","volume":"125","author":"Friedman","year":"2009","journal-title":"Int. J. Cancer"},{"year":"1993","series-title":"24 Month Chronic Toxicity and Oncogenicity Study in the Rat with MGK-264 (Study No. 552-030)","author":"Goldenthal","key":"10.1016\/j.yrtph.2025.105834_bib19"},{"key":"10.1016\/j.yrtph.2025.105834_bib20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/00498254.2018.1437300","article-title":"Comparison of the hepatic and thyroid gland effects of sodium phenobarbital and pregnenolone-16alpha-carbonitrile in wild-type and constitutive androstane receptor (CAR)\/pregnane X receptor (PXR) knockout rats","volume":"49","author":"Haines","year":"2019","journal-title":"Xenobiotica"},{"key":"10.1016\/j.yrtph.2025.105834_bib21","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1007\/s00204-020-02936-7","article-title":"Inhibition and induction of CYP enzymes in humans: an update","volume":"94","author":"Hakkola","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105834_bib22","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1177\/0192623312448935","article-title":"Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes--conclusions from the 3rd International ESTP Expert Workshop","volume":"40","author":"Hall","year":"2012","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.yrtph.2025.105834_bib23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1289\/ehp.106-1533202","article-title":"Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis","volume":"106","author":"Hard","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.yrtph.2025.105834_bib24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1289\/ehp.98106447","article-title":"Risk assessment of thyroid follicular cell tumors","volume":"106","author":"Hill","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.yrtph.2025.105834_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/toxsci\/55.1.78","article-title":"Differential effects of microsomal enzyme inducers on in vitro thyroxine (T4) and triiodothyronine (T3) glucuronidation","volume":"55","author":"Hood","year":"2000","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105834_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/toxsci\/50.1.45","article-title":"Effects of phenobarbital, pregnenolone-16alpha-carbonitrile, and propylthiouracil on thyroid follicular cell proliferation","volume":"50","author":"Hood","year":"1999","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105834_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/toxsci\/49.2.263","article-title":"Sensitivity of thyroid gland growth to thyroid stimulating hormone (TSH) in rats treated with antithyroid drugs","volume":"49","author":"Hood","year":"1999","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105834_bib25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/taap.1999.8752","article-title":"Effects of microsomal enzyme inducers on thyroid-follicular cell proliferation, hyperplasia, and hypertrophy","volume":"160","author":"Hood","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105834_bib29","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/toxsci\/kfx279","article-title":"Screening the ToxCast phase 1 chemical library for inhibition of deiodinase type 1 activity","volume":"162","author":"Hornung","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105834_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/taap.1996.8032","article-title":"Mechanism of thiazopyr-induced effects on thyroid hormone homeostasis in male sprague\u2013dawley rats","volume":"142","author":"Hotz","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105834_bib31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1289\/ehp.98106437","article-title":"Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents","volume":"106","author":"Hurley","year":"1998","journal-title":"Environ. Health Perspect."},{"volume":"vol. 79","first-page":"1017","year":"2001","key":"10.1016\/j.yrtph.2025.105834_bib32"},{"key":"10.1016\/j.yrtph.2025.105834_bib33","series-title":"BIochemical Toxicology: A Practical Approach","first-page":"183","article-title":"Preparation and characterisation of microsomal fractions for studies of xenobiotic metabolism","author":"Lake","year":"1987"},{"key":"10.1016\/j.yrtph.2025.105834_bib34","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/cbic.200700682","article-title":"Small-molecule inhibitors of sodium iodide symporter function","volume":"9","author":"Lecat-Guillet","year":"2008","journal-title":"Chembiochem"},{"key":"10.1016\/j.yrtph.2025.105834_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4158\/EP.6.2.221","article-title":"Thyroid cancer and Graves' disease: the controversy ten years later","volume":"6","author":"Mazzaferri","year":"2000","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.yrtph.2025.105834_bib36","series-title":"A Mechanistic Relationship between Thyroid Follicular Cell Tumours and Hepatocellular Neoplasms in Rodents","first-page":"61","author":"McClain","year":"1999"},{"key":"10.1016\/j.yrtph.2025.105834_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jat.2949","article-title":"New developments in the evolution and application of the WHO\/IPCS framework on mode of action\/species concordance analysis","volume":"34","author":"Meek","year":"2014","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105834_bib38","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/713608373","article-title":"A framework for human relevance analysis of information on carcinogenic modes of action","volume":"33","author":"Meek","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105834_bib39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jat.2984","article-title":"Mode of action human relevance (species concordance) framework: evolution of the Bradford Hill considerations and comparative analysis of weight of evidence","volume":"34","author":"Meek","year":"2014","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105834_bib40","doi-asserted-by":"crossref","DOI":"10.1289\/EHP5297","article-title":"Evaluating chemicals for thyroid disruption: opportunities and challenges with in vitro testing and adverse outcome pathway approaches","volume":"127","author":"Noyes","year":"2019","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.yrtph.2025.105834_bib41","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/toxsci\/kfy302","article-title":"Screening the ToxCast Phase 1, Phase 2, and e1k Chemical Libraries for Inhibitors of Iodothyronine Deiodinases","volume":"168","author":"Olker","year":"2019","journal-title":"Toxicol. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.yrtph.2025.105834_bib42","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/toxsci\/kfq338","article-title":"Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities","volume":"120","author":"Omiecinski","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105834_bib43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/toxsci\/kfw034","article-title":"Tiered high-throughput screening approach to identify thyroperoxidase inhibitors within the ToxCast phase I and II chemical libraries","volume":"151","author":"Paul Friedman","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105834_bib44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.tox.2013.08.006","article-title":"Cross-species analysis of thyroperoxidase inhibition by xenobiotics demonstrates conservation of response between pig and rat","volume":"312","author":"Paul","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.yrtph.2025.105834_bib45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1021\/tx400310w","article-title":"Development of a thyroperoxidase inhibition assay for high-throughput screening","volume":"27","author":"Paul","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105834_bib46","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00204-008-0332-8","article-title":"Inhibition and induction of human cytochrome P450 enzymes: current status","volume":"82","author":"Pelkonen","year":"2008","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.yrtph.2025.105834_bib47","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/00498254.2019.1629044","article-title":"An assay for screening xenobiotics for inhibition of rat thyroid gland peroxidase activity","volume":"50","author":"Price","year":"2020","journal-title":"Xenobiotica"},{"key":"10.1016\/j.yrtph.2025.105834_bib48","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1007\/s00415-020-10379-4","article-title":"Anti-seizure medication is not associated with an increased risk to develop cancer in epilepsy patients","volume":"268","author":"Stritzelberger","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.yrtph.2025.105834_bib49","article-title":"Weight of evidence and human relevance evaluation of the benfluralin mode of action in rats (Part II): thyroid carcinogenesis","volume":"117","author":"Strupp","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105834_bib50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/abbi.1996.0222","article-title":"Mechanism of simultaneous iodination and coupling catalyzed by thyroid peroxidase","volume":"330","author":"Taurog","year":"1996","journal-title":"Arch. Biochem. Biophys."},{"year":"2002","series-title":"Hepatocellular hypertrophy.HED Guidance Document # G2002.01","key":"10.1016\/j.yrtph.2025.105834_bib51"},{"year":"2006","series-title":"Reregistration Eligibility Decision for N-Octyl Bicycloheptene Dicarboximide (MGK-264)","key":"10.1016\/j.yrtph.2025.105834_bib52"},{"year":"2024","series-title":"MGK-264: Cancer Reassessment of the Cancer Assessment Review Committee","key":"10.1016\/j.yrtph.2025.105834_bib53"},{"key":"10.1016\/j.yrtph.2025.105834_bib54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/taap.2001.9278","article-title":"Increased biliary excretion of thyroxine by microsomal enzyme inducers","volume":"176","author":"Vansell","year":"2001","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2025.105834_bib55","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0014-5793(93)80151-J","article-title":"Glucuronidation of thyroid hormone by human bilirubin and phenol UDP-glucuronyltransferase isoenzymes","volume":"324","author":"Visser","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.yrtph.2025.105834_bib56","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/toxsci\/67.2.207","article-title":"Thyroid toxicity due to subchronic exposure to a complex mixture of 16 organochlorines, lead, and cadmium","volume":"67","author":"Wade","year":"2002","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2025.105834_bib57","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0163-7258(96)00067-8","article-title":"Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion","volume":"71","author":"Whysner","year":"1996","journal-title":"Pharmacol. Therapeut."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230025000649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230025000649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:08:02Z","timestamp":1762283282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230025000649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":57,"alternative-id":["S0273230025000649"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2025.105834","relation":{},"ISSN":["0273-2300"],"issn-type":[{"type":"print","value":"0273-2300"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mode of action analysis for rat thyroid gland follicular cell tumor formation by MGK-264 and human relevance","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2025.105834","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105834"}}